What is Dyne Therapeutics, Inc. (DYN)?
Dyne Therapeutics, Inc. is a biotechnology company focused on the development of precision genetic medicines for the treatment of serious diseases. The company employs a proprietary platform to create targeted therapies that enhance delivery of oligonucleotide-based drugs to muscle tissues. Its research and development efforts concentrate on neuromuscular disorders, aiming to address underlying genetic causes. The company’s pipeline includes candidates designed to modulate gene expression and protein production. Collaborations with academic institutions and industry partners support its scientific and clinical programs. The company integrates molecular biology, chemistry, and delivery technologies to advance novel therapeutic approaches.
Dyne Therapeutics, Inc. Stock Price Today: Live Overview
The price today is shaped by market dynamics as Dyne Therapeutics, Inc. holds a price of $17.20. Its price today has oscillated between $17.01 and $18.75, with a daily change of 0%.
FAQ: Dyne Therapeutics, Inc. (DYN)
What is the current price of DYN stock?
Dyne Therapeutics, Inc. is trading at $17.20.
Does DYN pay dividends?
Dyne Therapeutics, Inc. does not pay dividends.
Does DYN have a formal corporate presence or regional headquarters in the UAE?
Dyne Therapeutics, Inc. has no official presence in the UAE and operates through partners.
What is DYN best known for?
The company is most famous for developing targeted genetic medicines for rare diseases.
What assets are typically shown together with DYN?
Commonly shown alongside DYN: Lloyd Focused Equity UCITS ETF, ASML Holding N.V., Ridley Corporation Limited
Latest shares articles



